|LETTER TO THE EDITOR
|Ahead of print publication
Vitamin D supplementation and serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A summary of clinical evidences from a tropical country with a high incidence of hepatitis-related hepatocellular carcinoma
Pathum Sookaromdee1, Viroj Wiwanitki2
1 Private Academic Consultant, Bangkok, Thailand
2 Department of Honorary, Dr DY Patil University, Pune, Maharashtra, India
|Date of Submission||24-Feb-2021|
|Date of Decision||24-Mar-2021|
|Date of Acceptance||25-Mar-2021|
|Date of Web Publication||15-Feb-2022|
Private Academic Consultant, Bangkok
Source of Support: None, Conflict of Interest: None
|How to cite this URL:|
Sookaromdee P, Wiwanitki V. Vitamin D supplementation and serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A summary of clinical evidences from a tropical country with a high incidence of hepatitis-related hepatocellular carcinoma. J Can Res Ther [Epub ahead of print] [cited 2022 Nov 29]. Available from: https://www.cancerjournal.net/preprintarticle.asp?id=337712
Hepatitis C is an important viral infection. This infection is common in East and South Asia and it is an important cause of hepatocellular carcinoma in the endemic area. The early management of the infection by antiviral therapy is commended aiming at decreased hepatic fibrogenesis that can further progress to carcinogenesis. Adding to antiviral therapy, nutritional supplementation is also proposed for its usefulness in managing chronic hepatitis C. Vitamin D supplementation is recommended.,
The effect of Vitamin D supplementation in the management of chronic hepatitis C cases is interesting. In a report from India, Behera et al. found that there is no significant effect. However, a report from Thailand presented a different finding that Vitamin D supplementation is useful. Among the reports from the same area such as Thailand, a country with a high incidence of hepatitis C and hepatitis-related hepatocellular carcinoma, the inconclusive results are observed., Here, the authors perform a summative analysis on the available data on trials on Vitamin D supplementation and serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients in Thailand.
Based on the two available clinical trials, there are overall 66 and 67 cass in vitamin D supplementation and control groups. The observed fibrogenic markers (transforming growth factor-beta 1 and tissue inhibitors of matrix metalloproteinases 1) at 6 weeks are summarized and analyzed using ANOVA [Table 1]. According to this analysis, there is no specific difference of both the studied biomarkers at pre-and post-vitamin D supplementation in both vitamin D supplementation and placebo group (P > 0.05). This can imply that vitamin D supplementation might not affect hepatic fibrogenesis prevention in chronic hepatitis C. The usefulness of Vitamin D supplementation for the prevention of hepatitis-associated hepatocellular carcinoma has to be re-evaluated.
|Table 1: Effect of Vitamin D supplementation on serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients|
Click here to view
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
| > References|| |
Kondo Y. Hepatitis C infected patients need Vitamin D3 supplementation in the era of direct acting antivirals treatment. World J Gastroenterol 2017;23:1325-7.
Lange CM, Miki D, Ochi H, Nischalke HD, Bojunga J, Bibert S, et al
. Genetic analyses reveal a role for Vitamin D insufficiency in HCV-associated hepatocellular carcinoma development. PLoS One 2013;8:e64053.
Behera MK, Shukla SK, Dixit VK, Nath P, Abhilash VB, Asati PK, et al
. Effect of Vitamin D supplementation on sustained virological response in genotype 1/4 chronic hepatitis C treatment-naïve patients from India. Indian J Med Res 2018;148:200-6.
] [Full text]
Komolmit P, Kimtrakool S, Suksawatamnuay S, Thanapirom K, Chattrasophon K, Thaimai P, et al
. Vitamin D supplementation improves serum markers associated with hepatic fibrogenesis in chronic hepatitis C patients: A randomized, double-blind, placebo-controlled study. Sci Rep 2017;7:8905.
Sriphoosanaphan S, Thanapirom K, Kerr SJ, Suksawatamnuay S, Thaimai P, Sittisomwong S, et al
. Effect of Vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: A randomized, double-blind, placebo-controlled trial. PeerJ 2021;9:e10709.